2m 2m 2m 2m 2m 2m 2m
Astrana Health (ASTH)
NASDAQ
$41.44+$1.85 (+4.67%)
Price as of Jun 23, 2026 6:23 PM EDT- $2.0BMarket Cap
- 57.92%1-Year Change
- Medical Care FacilitiesIndustry
Astrana Health (ASTH)
$41.44+$1.85 (+4.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.9B +43.68% | 2.0B +47.26% | 1.4B +23.08% | 1.1B +47.14% | |
Cost of Revenue | 2.8B +61.09% | 1.8B +50.48% | 1.2B +24.03% | 944.7M +58.47% | |
Gross Profit | 84.0M -69.15% | 272.1M +29.35% | 210.4M +18.05% | 178.2M +6.69% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 45.7M +63.82% | 27.9M +57.35% | 17.7M +1.17% | 17.5M +0.15% | |
Total Operating Expenses | 3.1B +59.53% | 1.9B +49.39% | 1.3B +25.21% | 1.0B +53.89% | |
Operating Profit | 78.5M -12.12% | 89.3M +5.60% | 84.6M -18.85% | 104.3M +6.20% | |
Interest Income | 12.2M -16.20% | 14.5M +2.11% | 14.2M +619.03% | 2.0M +25.78% | |
Interest Expense | -4.1M +127.78% | -1.8M -88.82% | -16.1M +103.31% | -7.9M +46.83% | |
Interest Income and Expense and Net | 8.1M -36.60% | 12.7M +770.96% | -1.9M -68.14% | -5.9M +55.48% | |
Total Nonoperating Income and Expense | -38.9M +356.15% | -8.5M -263.29% | 5.2M +129.61% | -17.6M -13.62% | |
Income before Taxes | 39.6M -50.99% | 80.8M -10.04% | 89.8M +3.72% | 86.6M +11.41% | |
Income Taxes | 15.5M -49.72% | 30.9M -3.45% | 32.0M -21.74% | 40.9M +43.65% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 22.5M -47.89% | 43.1M -28.93% | 60.7M +34.42% | 45.2M -38.84% | |
Net Income from Continuing Operations Applicable to Common | 39.6M -50.99% | 80.8M -10.04% | 89.8M +3.72% | 86.6M +11.41% | |
Basic EPS and Net Income | 0.46 -49.45% | 0.91 -30.00% | 1.30 +30.00% | 1.00 -40.83% | |
Diluted EPS and Net Income | 0.46 -48.89% | 0.90 -30.23% | 1.29 +30.30% | 0.99 -39.26% | |
Basic Weighted Average Shares | 49.1M +3.11% | 47.6M +2.24% | 46.6M +3.52% | 45.0M +2.61% | |
Diluted Weighted Average Shares | 49.4M +2.91% | 48.0M +2.20% | 46.9M +2.94% | 45.6M +0.44% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 429.5M +48.89% | 288.5M -1.82% | 293.8M +2.01% | 288.0M +23.57% | |
Short-Term Investments | N/A N/A | 2.4M -4.80% | 2.5M -55.13% | 5.6M -89.58% | |
Cash and Cash Equivalents and Short-Term Investments | 429.5M +47.67% | 290.8M -1.85% | 296.3M +0.92% | 293.6M +2.47% | |
Total Current Assets | 863.3M +35.21% | 638.5M +38.35% | 461.5M +7.80% | 428.1M +7.36% | |
Accumulated Depreciation | 29.7M +20.20% | 24.7M +7.92% | 22.9M -4.87% | 24.0M +17.98% | |
Property and Plant and Equipment and Net | 57.3M +301.65% | 14.3M +99.05% | 7.2M -93.39% | 108.5M +104.07% | |
Total Long-Term Assets | 1.4B +89.19% | 716.4M +51.83% | 471.9M -12.31% | 538.1M +18.63% | |
Total Assets | 2.2B +63.75% | 1.4B +45.16% | 933.4M -3.40% | 966.2M +13.36% | |
Income Taxes Payable | 5.5M +20.55% | 4.6M +11.86% | 4.1M -77.98% | 18.5M +89.14% | |
Total Short-Term Debt | 47.9M +410.56% | 9.4M -51.92% | 19.5M +3,050.24% | 619,000 -20.64% | |
Total Current Liabilities | 615.3M +68.29% | 365.6M +67.19% | 218.7M +47.15% | 148.6M +28.81% | |
Total Long-Term Debt | 990.9M +132.99% | 425.3M +64.25% | 258.9M +27.31% | 203.4M +11.19% | |
Total Long-Term Liabilities | 1.0B +119.96% | 475.1M +56.33% | 303.9M +17.32% | 259.1M +17.22% | |
Total Liabilities | 1.7B +97.49% | 840.7M +60.88% | 522.6M +28.19% | 407.7M +21.20% | |
Retained Earnings | 308.4M +7.72% | 286.3M +17.75% | 243.1M +33.28% | 182.4M +27.01% | |
Total Stockholders Equity | 779.3M +9.34% | 712.7M +16.04% | 614.2M +13.21% | 542.6M +19.36% | |
Total Shares Outstanding | 48.9M +1.99% | 47.9M +9,485.97% | 500,000 N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | 114.6M +119.54% | 52.2M -23.49% | 68.2M -16.93% | 82.1M +16.77% | |
Capital Expenditures | 10.1M +25.84% | 8.0M -71.85% | 28.5M +24.36% | 22.9M +19.34% | |
Cash from Investing Activities | -539.0M +180.15% | -192.4M +193.63% | -65.5M +821.17% | -7.1M -143.00% | |
Dividends Paid | 7.9M +95.37% | 4.0M -93.50% | 62.1M +342.44% | 14.0M -54.87% | |
Cash from Financing Activities | 569.3M +321.28% | 135.1M +3,850.48% | 3.4M +117.03% | -20.1M -57.94% | |
Financials Ratio | |||||
Gross Margin | 2.87% -78.53% | 13.37% -12.16% | 15.22% -4.09% | 15.87% -27.49% | |
Operating Margin | 2.69% -38.83% | 4.39% -28.29% | 6.12% -34.07% | 9.29% -27.82% | |
Return on Assets | 1.26% -66.63% | 3.77% -41.01% | 6.39% +28.69% | 4.97% -43.84% | |
Return on Equity | 3.01% -53.65% | 6.50% -38.05% | 10.50% +15.86% | 9.06% -51.83% | |
Revenue Growth | 43.68% -7.59% | 47.26% +104.75% | 23.08% -51.03% | 47.14% +326.25% | |
Current Ratio | 1.40 -19.66% | 1.75 -17.25% | 2.11 -26.74% | 2.88 -16.65% | |
Cash Ratio | 0.70 -11.53% | 0.79 -41.28% | 1.34 -30.67% | 1.94 -4.07% | |
Debt-to-Equity Ratio | 1.33 +118.56% | 0.61 +34.55% | 0.45 +20.56% | 0.38 -6.95% | |
Debt-to-Assets Ratio | 0.47 +45.95% | 0.32 +7.54% | 0.30 +41.31% | 0.21 -2.04% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow